The Current Role of Radiotherapy in the Treatment of Invasive Bladder Cancer

Critical Reviews in Oncogenesis

Volumn 7, Issue 5-6, 1996, Pages 457-464

  Benda, Rashmi K ^a   Porter, Arthur T ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Bladder neoplasm; Invasive; Radiation

Indexed keywords

CISPLATIN; FLOXURIDINE; METHOTREXATE; VINBLASTINE;

BEAM THERAPY; BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CYSTECTOMY; HUMAN; REVIEW;

BRACHYTHERAPY; CLINICAL TRIALS; COMBINED MODALITY THERAPY; HUMANS; NEOPLASM INVASIVENESS; RADIOTHERAPY; URINARY BLADDER NEOPLASMS;

EID: 0030319525     PISSN: 08939675     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevOncog.v7.i5-6.40     Document Type: Article

References (64)

1. Anderstrom, C., S. Johansson, S. Nilsson, B. Unsgaard, and L. Wahlqvist: A prospective randomized study of preoperative irradiation with cystectomy or cystectomy alone for invasive bladder carcinoma. Eur. Urol., 142-147 (1983).
2. Awwad, H., H. A. El-Baki, N. El-Bolkainy, et al.: Preoperative irradiation of T3 carcinoma in bilharzial bladder: a comparison between hyperfractionation and conventional fractionation. Int. J. Radiat. Oncol. Biol. Phys., 5:787-794 (1979).
3. Babaian, R. J., D. E. Johnson, L. Llamas, et al: Metastases from transitional cell carcinoma of the urinary bladder. Urology, 16:142-144 (1980).
4. Begg, A., L. Moonen, I. Hofland, M. Dessing, and H. Bartelink: Human tumor cell kinetics using a monoclonal antibody against iododeoxyuridine: intratumor sampling variations. Radiother. Oncol., 11:337-347 (1988).
5. Blackard, C. E. and D. P. Byar: Group VACUR. Results of a clinical trial of surgerya and radiation in stages II and III carcinoma of the bladder. J. Urol., 108:875-878 (1972).
6. Blandy, J. P., H. R. England, S. J. W. Evans, et al.: T3 Bladder cancer-the case for salvage cystectomy. Br. J. Urol., 52:506-510 (1980).
7. Bloom, H. J. G., W. F. Hendry, D. M. Wallace, and R. G. Skeet: Treatment of T3 bladder cancer: controlled trial of preoperative radiotherapy and radical cystectomy versus radical radiotherapy. Br. J. Urol., 54:136-151 (1982).
8. Coppin, C., M. Gospodarowitz, P. Dixon, I. Tannock, B. Zee, andL. Sullivan: Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or radical radiation. Proc. Am. Soc. Clinc. Oncol., 11:198 [Abstract] (1992).
9. Davidson, S. E., R. P. Symonds, M. P. Snee, S. Upadhyay, T. Habeshaw, and A. G. Robertson: Assessment of factors influencing the outcome of radiotherapy for bladder cancer. Br. J. Urol., 66:288-293 (1990).
10. DeNeve, W., M. L. Lybeert, C. Goor, et al.: Radiotherapy for T2 and T3 carcinoma of the bladder: the influence of overall treatment time. Rad. Oncol., 36:183-188 (1995).
11. Duncan, W. and P. M. Quilty: The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy. Radioiher. Oncol., 7:299-310 (1986).
12. Dunst, J., C. Bornhof, A. Altendorf-Hofmann, C. Wittekind, K. M. Schrott, and R. Sauer: Organ-preserving therapy in invasive bladder carcinoma. Deutsch. Med. Wochenschr., 117:1783-1788 (1992).
13. Edsmyr, F., K. Anderson, P. L. Eposti, B. Littbrand, and B. Nilsson: Irradiation therapy with multiple small fractions per day in urinary bladder cancer. Radiother. Oncol., 4:197-203 (1985).
14. Fitzpatrick, J. M., A. B. West, M. R. Butler, et al.: Superficial bladder tumors (stage Ta, grade 1 and 2): the importance of recurrence pattern following initial resection. J. Urol., 135:920 (1986).
15. Fossa, S. D., H. Waehre, N. Aass, A. B. Jacobsen, D. R. Olsen, and S. Ous: Bladder cancer definitive radiation therapy of muscle-invasive bladder cancer. A retrospective analysis of 317 patients. Cancer, 72:3036-3043 (1993).
16. Frazier, H. A., J. E. Robertson, and D. F. Paulson: Complications of radical cystectomy and urinary diversion: a retrospective review of 675 cases in 2 decades. J. Urol., 148:1401 (1992).
17. Ghoneim, M. A., A. K. Ashmallah, H. K. Awaad, and W. F. Whitmore, Jr.: Randomized trial of cystectomy with or without preoperative radiotherapy for carcinoma of the bilharzial bladder. J. Urol., 134:266-268 (1985).
18. Goffinet, D. R., M. J. Schneider, E. J. Glatstein, et al.: Bladder cancer: results of radiation therapy in 384 patients. Radiology, 117:149-153 (1975).
19. Gospodarowicz, M. K. and J. P. Blandy: Radiation therapy for organ conservation for invasive bladder carcinoma. In: Comprehensive Textbook of Genitourinary Oncology, Scardino, P. T., W. U. Shipley, and D. S. Coffey, Eds., Vogelzang, NJ.
20. Gospodarowicz, M. K., M. V. Hawkins, G. A. Rawling, et al.: Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis. J. Urol., 142:1448-1454 (1989).
21. Gospodarowicz, M. K., W. D. Rider, C. W. Keen, et al.: Bladder cancer: long-term follow-up results of patients treated with radical radiation. J. Clin. Oncol., 3:155-161 (1991).
22. Greven, K. M., L. J. Solin, and G. E. Hanks: Prognosstic factors in patients with bladder carcinoma treated with definitive irradiation. Cancer, 65:908-912 (1990).
23. Heney, N. M., S. Ahmed, M. J. Flanagan, et al.: Superficial bladder cancer: progression and recurrence. J. Urol., 130:1083-1086 (1983).
24. Henry, K., J. Miller, M. Mori, S. Loening, and B. Fallon: Comparison of transurethral resection to radical therapies for stage .B bladder tumors. J. Urol., 140:964-967 (1988).
25. Herr, H. W.: Conservative management of muscle-infiltrating bladder cancer: prospective experience. J. Urol., 138:1162-1163 (1987).
26. Horwich, A., S. Pendlebury, and D. P. Dearnaley: Organ conservation in bladder cancer. Eur. J. Cancer, 31(suppl 5):208 (1995).
27. Housset, M., C. Maulard, Y. C, Chretien, et al.: Combined radiation and chemotherapy for invasive transitional cell carcinoma of the bladder: a prospective study. J. Clin. Oncol., 11:2150-2157 (1993).
28. Jacobsen, A. B., S. Lunde, S. Ous, et al.: T2-T3 bladder carcinomas treeated with definitive radiotherapy with emphasis on flow cytometric DNA ploidy values. Int. J. Radiat. Oncol., Biol. Phys., 17:923-929 (1989).
29. Jenkins, B. J., M. J. Caulfield, C. G. Fowler, et al.: Reappraisal of the role of radical radiotherapy and salvage cystectomy in the treatment of invasive (T2-T3) bladder cancer. Br. J. Urol., 62:343-346 (1988).
30. Kaufman, D. S., W. U. Shipley, P. P. Griffin, N. M. Heney, A. F. Althausen, and J. T. Efird: Selective preservation by combination treatment of invasive bladder cancer. N. Engl. J. Med., 329:1377-1382 (1993).
31. Loehrer, P. J., L. H. Einhorn, P. J. Elson, et al.: A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. J. Clin. Oncol., 10:1066-1073 (1992).
32. Mameghan, H., R. Fisher, J. Mameghan, et al.: Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder. Int. J. Radiat. Oncol. Biol. Phys., 31:247-254 (1995).
33. Monnen, L. M, S. Horenblas, J. C. Van der Voet, et al.: Bladder conservation in selected T1G3 and muscle invasive T2-T3a bladder carcinoma using combination therapy of surgery and iridium-192 implantation. Brit. J. Urol., 74:322-327 (1994).
34. Naslund, I., B. Nilsson, and B. Littbrand: Hyperfractionated radiotherapy of bladder cancer: a 10 year follow up of a randomized clinical trial. Acta Onc., 33:397-402 (1994).
35. Parsons, J. T. and R. R. Million: Role of planned preoperative irradiation in the management of clinical stage B2-C (T3) bladder carcinoma in the 1980s. Semin. Surg. Oncol., 5:255-265 (1989).
36. Prout, G. R. Jr., B. A. Barton, P. P. Griffin, et al.: Treated history of noninvasive grade 1 transitional cell carcinoma. J. Urol., 148:1413-1419 (1992).
37. Prout, G. R. Jr., P. P. Griffin, and W. U. Shipley: Bladder carcinoma as a systemic disease. Cancer, 43:2532-2539 (1979).
38. Rozan, R., E. Albuisson, D. Donnarieix, et al.: Interstitial iridium-192 for bladder cancer (a multicentric survey of 205 patients). Int. J. Radiat Oncol. Biol. Phys., 24:469-477 (1992).
39. Sauer, R., J. Dunst, A. Altendorf-Hofmann, H. Fischer, C. Bornhof, and K. M. Schrott: Radiotherapy with and without cisplatin in bladder cancer. Int. J. RadiAt. Oncol. Biol. Phys., 19:687-691 (1990).
40. Sell, A., A. Jakobsen, and B. Nerstrom: Treatment of advanced bladder cancer category T2, T3, T4a: a randomized multicenter study of preoperative irradiation and cystectomy versus radical irradiation and early salvage cy stectomy for residual tumor DAVEC A protocol 8201: Danish Vesical Cancer Group. Scan. J. Urol. Nephrol., 1388:193-201 (1991).
41. Shearer, R. J., C. E. Chilvers, H. J. G. Bloom, et al.: Adjuvant chemotherapy in T3 carcinoma of the bladder. Br. J. Urol., 62:558-564 (1988).
42. Shipley, W. U., G. R. Prout, Jr., A. B. Einstein, et al.: Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery. JAMA, 258:931-935 (1987).
43. Shipley, W. U., G. R. Prout, Jr., S. D. Kaufman, and T. Perrone: Invasive bladder carcinoma. The importance of initial transurethral surgery and other significant prognostic factors for improved survival with full-dose irradiation. Cancer, 60:514-520 (1987).
44. Shipley, W. U. and M. A. Rose: Bladder cancer. The selection of patients for treatment by full-dose irradiation. Cancer, 55:2278-2284 (1985).
45. Shipley, W. U., M. A. Rose, T. L. Perrone, C. M. Mannix, N. M. Heney, G. R. Prout, Jr.: Full dose irradiation for patients with invasive bladder carcinoma: clinical and histological factors prognostic of improved survival. J. Urol., 134:679-683 (1985).
46. Shipley, W. U., E. Van der Schueren, T. Kitigawa, et al.: Guidelines for radiation therapy in clinical research on bladder cancer. Prog. Clin. Biol. Res., 221:109-121 (1986).
47. Skinner, D. G., J. R. Daniels, C, A. Russell, et al.: The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J. Urol., 145:459-467 (1991).
48. Slack, N. H., I. D. J. Bross, G. R. Prout, Jr.: Five-year follow-up results of a collaborative study of therapies for carcinoma of the bladder. J. Surg. Oncol., 9:393-405 (1977).
49. Smaaland, R., L. A. Akslen, B. Tender, A. Mehus, K. Lote, and G. Albrektsen: Radical radiation treatment of invasive and locally advanced bladder carcinoma in elderly patients. Br. J. Urol., 67:61-69 (1991).
50. Smith, J. A. Jr., E. D. Crawford, B. L. Blumenstein, J. Paradelo, and B. R. Herschman: Preoperative irradia- tion plus radical cystectomy versus surgery alone for invasive bladder cancer: final results of a rancomized, prospective Southwest Oncology Group study (Abstract). J. Urol., 149S:316A (1993).
51. Sur, R. K., J. Clinkard, W. G. Jones, et al.: Changes in target volume during radiotherapy treatment of invasive bladder carcinoma. Clin. Oncol., 5:30-33 (1993).
52. Swanson, D. A., A. Liles, and G. K. Zagars: Preoperative irradiation and radical cystectomy for stages T2 and T3 squamous cell carcinoma of the bladder. J. Urol., 143:37-40 (1990).
53. Tait, D., A. Nahum, C. Southall, M. Chow, and J. R. Yarnold: Benefits expected from simple conformal radiotherapy in the treatment of pelvic tumors. Radiother. Oncol., 13:23-30 (1988).
54. Tait, D. M., A. E. Nahum, L. Rigby, et al.: Conformal radiotherapy of the pelvis:assessment of acute toxicity. Radiother. Oncol., 29:117-126 (1993).
55. Tester, W., R. Caplan, J. Heaney, P. Venner, R. Whittington, R. Byhardt, L. True, and W. Shipley: Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of RTOG phase II trial 8802. JCO, 14:119-126 (1996).
56. Tester, W., A. Porter, S. Asbell, C. Coughlin, J. Heaney, J. Krall, K. Martz, P. Venner, and E. Hammond: Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12. Int. J. Radiat. Oncol. Biol. Phys., 25:783-790 (1993).
57. Turner, S., R. Swindell, N. Bowl, G. Read, and R. Cowan: Bladder movement during radiation therapy for bladder cancer: implication for treatment planning. Int. J. Radiat. Oncol. Biol. Phys., 30:199-200 (1994).
58. Vale, J. A., R. P. A'Hern, K. Liu, et al.: Predicting the outcome of radical radiotherapy for invasive bladder cancer. Eur. Urol., 24:48-51 (1993).
59. Van der Werf-Messing, B., R. S. Menon, and W. C. J. Hop: Cancer of the urinary bladder category T2, T3 treated by interstitial radium implant: second report. Int. J. Radiat. Oncol. Biol. Phys., 9:481-485 (1993).
60. Vikram, B., S. Malamud, P. Silverman, H. Hecht, and H. Grabstald: A pilot study of chemotherapy alternating with twice-a-day accelerated radiation therapy as an alternative to cystectomy in muscle infiltrating (stages T2 and T3) cancer of the bladder: preliminary results. J. Urol., 151:602-604 (1994).
61. Wijkstrom, H., B. Nilsson, and B. Tribukait: DNA analysis in predicting survival of irradiated patients with transitional cell carcinoma of bladder. Br. J. Urol., 69:49-55 (1992).
62. Wijnmalen, A. and B. H. P. Van der Werf-Messing: Factors influencing the prognosis in bladder cancer. Int. J. Radiat. Oncol. Biol. Phys., 12:559-565 (1986).
63. Young, H. H. and W. A. Frontz: Some new methods in the treatment of carcinoma of the lower genitourinary tract with radium. J. Urol., 1:505-541 (1917).
64. Yu, W. S., R. H. Sagerman, C. T. Chung, P. S. Dalal, and G. A. King: Bladder carcinoma. Experience with radical and preoperative radiotherapy in 421 patients. Cancer, 56:1293-1299 (1985).